|
|
| Line 1: |
Line 1: |
| {{SI}}
| |
| {{CMG}}
| |
|
| |
|
|
| |
|
| |
| ==Overview==
| |
|
| |
| <small>'''''Synonyms / Brand Names:''''' Nefazodona, Nefazodone Hcl, Nefazodone hydrochloride, Nefazodonum, Dutonin, Serzone </small>
| |
|
| |
| ==Dosing and Administration==
| |
| The recommended starting dose for Nefazodone hydrochloride tablets is 200 mg/day, administered in two divided doses (BID). In the controlled clinical trials establishing the antidepressant efficacy of Nefazodone, the effective dose range was generally 300 to 600 mg/day. Consequently, most patients, depending on tolerability and the need for further clinical effect, should have their dose increased. Dose increases should occur in increments of 100 mg/day to 200 mg/day, again on a BID schedule, at intervals of no less than 1 week. As with all antidepressants, several weeks on treatment may be required to obtain a full antidepressant response.
| |
|
| |
| ----
| |
| {{FDA}}
| |
|
| |
| [[Category:Drugs]]
| |
| {{WH}}
| |
|
| |
| {{WS}}
| |